What does ISEENOW do?

ISEENOW is a brand strategy and identity agency in Sydney. We help founders turn early ideas and intuition into clear brand foundations and identity systems through strategy, language, visual identity, and voice.

Early-stage startups, seed/Series A founders, small to mid-sized businesses, founder-led companies, and Russian-speaking founders building English-language brands.

What is the ISEENOW Brand Clarity Method?

A founder-led, psychology-informed framework that turns founder vision, experience, intuition, and taste into a structured brand foundation. It clarifies identity before expression.

For Investor Trust. Biotech branding designed to communicate credibility and scientific depth.

For Investor Trust — portfolio thumbnail

intro

Leeners is a biotech company developing advanced solutions in health and science. Their breakthrough work needed a brand identity that would make complex innovation approachable, credible, and future-oriented — speaking both to investors and partners, while keeping the human side of biotechnology at the core.

Case study

Challenge

The biotech sector is often seen as distant and overly technical. Leeners needed an identity that balanced scientific precision with clarity and trust — helping them stand out to stakeholders while still reflecting the depth of their research and innovation.

Solution

We designed a brand platform rooted in clarity, focus, and transformation.

Visual Identity: A modern logotype with geometric precision paired with a clean graphic system. The design uses gradients and modular patterns as a metaphor for molecular connections and constant progress.
Tone of Voice: Clear, professional, and confident — avoiding jargon, yet strong enough to communicate scientific expertise.
Color Palette: Cool, future-driven tones (blue, green, white) to evoke trust, health, and forward momentum.

This system ensures Leeners can communicate equally well in scientific presentations, investor decks, and public channels.

Result

Leeners left the project with a clearer biotech brand foundation and a visual identity that could support both scientific credibility and business growth.

The new system gave the company a more confident way to present itself across the website, presentations, documentation, 3D video materials, and partner-facing communication.

What changed:

• The brand became easier to explain to investors, partners, and non-scientific audiences.
• The identity moved from separate visual directions into one coherent brand system.
• Complex pharmaceutical innovation was translated into clearer language and visual structure.
• The company gained a stronger foundation for presentations, partnerships, and future communication.
• The brand now connects scientific depth with a more distinctive and commercially ready presence.

‍

brand identity

No items found.

Credits

Creative director, strategist: Irina Chernyshenko; Brand designer: Daria Osipova; Сopywriter: Galina Evdokimova

Industry

Biotechnology, Drug Development

Website

https://leeners.pro/en/about

Services

Verbal identity

Visual identity

Voice identity

Digital design

Presentation

Merch

client's feedback

Leeners Biotech develops pharmaceutical products — from concept to the implementation of manufacturing technology.We create biopharmaceutical solutions inspired by nature and life processes. As a company operating at the intersection of science and practical application, it was important for us that our brand reflect both scientific depth and innovation.Irina helped us clearly articulate our positioning. She listened carefully, asked precise questions, and helped structure ideas that previously existed more as a collection of thoughts and directions. At the same time, she preserved the direction we already envisioned for the company and helped give it a form that is understandable not only within the scientific community.

The developed brand system and visual language now live consistently across all materials — from the website to presentations, documentation, and 3D videos. As a result, we present the company to investors and future partners with greater clarity and confidence, while maintaining our scientific identity.

Sergey Diduk

CEO, LEENERS